PNC Financial Services Group
BNGO icon

PNC Financial Services Group’s Bionano Genomics BNGO Stock Holding History

PNC Financial Services Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$37 – 4908
2024
Q4 		$37 Hold
2
– – ﹤0.01% 4742
2024
Q3 		$58 Hold
2
– – ﹤0.01% 4740
2024
Q2 		$86 Hold
2
– – ﹤0.01% 4721
2024
Q1 		$141 Hold
2
– – ﹤0.01% 4630
2023
Q4 		$240 Sell
2
-1
-33% -$104 ﹤0.01% 4470
2023
Q3 		$497 Buy
3
+2
+200% +$524 ﹤0.01% 4459
2023
Q2 		$393 Hold
1
– – ﹤0.01% 4610
2023
Q1 		$716 Hold
1
– – ﹤0.01% 4484
2022
Q4 		$942 Hold
1
– – ﹤0.01% 4422
2022
Q3 		$1K Hold
1
– – ﹤0.01% 4285
2022
Q2 		$1K Hold
1
– – ﹤0.01% 4315
2022
Q1 		$2K Hold
1
– – ﹤0.01% 4167
2021
Q4 		$2K Hold
1
– – ﹤0.01% 4124
2021
Q3 		$4K Buy
+1
New +$3.5K ﹤0.01% 3974

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

PNC Financial Services Group's BNGO Position: Q1 2025 in Review

PNC Financial Services Group sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 2 shares — an estimated $37 sold.

PNC Financial Services Group first reported a position in BNGO in Q3 2021 and held it in 14 quarters. The position peaked at $4K in Q3 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • PNC Financial Services Group reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 2 Bionano Genomics shares in Q1 2025, an estimated $37.
  • PNC Financial Services Group first reported a position in Bionano Genomics in Q3 2021 and held it in 14 quarters.
  • PNC Financial Services Group's Bionano Genomics position peaked at $4K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on PNC Financial Services Group's 13F filing for Q1 2025, filed 9 May 2025.